Forskning ved Københavns Universitet - Københavns Universitet

Forside

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Samuel Z Goldhaber
  • Alain Leizorovicz
  • Ajay K Kakkar
  • Sylvia K Haas
  • Geno Merli
  • Robert M Knabb
  • Jeffrey I Weitz
  • ADOPT Trial Investigators
  • Christian Tobias Torp-Pedersen
The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term prophylaxis with enoxaparin.
OriginalsprogEngelsk
TidsskriftNew England Journal of Medicine
Vol/bind365
Udgave nummer23
Sider (fra-til)2167-77
Antal sider11
ISSN0028-4793
DOI
StatusUdgivet - 8 dec. 2011

ID: 48592308